Research Article

The 341C/T polymorphism in the GSTP1 gene and lung cancer risk: a meta-analysis

Published: July 29, 2016
Genet. Mol. Res. 15(3): gmr8172 DOI: 10.4238/gmr.15038172

Abstract

Numerous studies have evaluated the association between the 341C/T polymorphism in glutathione S-transferase P1 (GSTP1) and lung cancer risk. However, there are conflicting results from previous studies. To derive a more precise estimation of the association, we conducted this meta-analysis. A comprehensive search was conducted to identify the eligible studies examining the GSTP1 341C/T polymorphism and lung cancer risk. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. The meta-analysis results showed that the GSTP1 341C/T polymorphism was significantly associated with lung cancer risk (TT vs CC: OR = 3.33, 95%CI = 1.49-7.44; CT vs CC: OR = 1.35, 95%CI = 1.10-1.65; dominant model: OR = 1.43, 95%CI = 1.05-1.96; recessive model: OR = 0.31, 95%CI = 0.14-0.70). The results indicate that the GSTP1 341C/T polymorphism may contribute to lung cancer risk. Conclusive evidence on the effects of this variant in lung cancer should be addressed in further studies.

Numerous studies have evaluated the association between the 341C/T polymorphism in glutathione S-transferase P1 (GSTP1) and lung cancer risk. However, there are conflicting results from previous studies. To derive a more precise estimation of the association, we conducted this meta-analysis. A comprehensive search was conducted to identify the eligible studies examining the GSTP1 341C/T polymorphism and lung cancer risk. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. The meta-analysis results showed that the GSTP1 341C/T polymorphism was significantly associated with lung cancer risk (TT vs CC: OR = 3.33, 95%CI = 1.49-7.44; CT vs CC: OR = 1.35, 95%CI = 1.10-1.65; dominant model: OR = 1.43, 95%CI = 1.05-1.96; recessive model: OR = 0.31, 95%CI = 0.14-0.70). The results indicate that the GSTP1 341C/T polymorphism may contribute to lung cancer risk. Conclusive evidence on the effects of this variant in lung cancer should be addressed in further studies.

About the Authors